The TSC1–TSC2 complex: a molecular switchboard controlling cell growth

Cited by (1,001)

Items 801–900 of 1,001

1. CREB3L4 promotes hepatocellular carcinoma progression and decreases sorafenib chemosensitivity by promoting RHEB-mTORC1 signaling pathway
   Zhengchen Jiang, Bowen Shi, Yun Zhang, Tianming Yu, Yang Cheng, Jiankang Zhu, Guangyong Zhang, Mingwei Zhong, Sanyuan Hu, Xiaomin Ma · 2024 · iScience
2. Neurocutaneous Manifestations of Genetic Mosaicism
   Maurice A. M. Van Steensel · 2015 · Journal of Pediatric Genetics
3. Lymphangioleiomyomatosis: a case report and review of diagnosis and treatment
   Yi Liu, Zhibin Guo, Chenlong Zhao, Xin Li, Hongyu Liu, Jun Chen · 2018 · OncoTargets and Therapy
4. A Slow-Digesting Carbohydrate Diet during Rat Pregnancy Protects Offspring from Non-Alcoholic Fatty Liver Disease Risk through the Modulation of the Carbohydrate-Response Element and Sterol Regulatory Element Binding Proteins
   Rafael Salto, Manuel Manzano, María Dolores Girón, Ainara Cano, Azucena Castro, José Dámaso Vílchez, Elena Cabrera, José M. López-Pedrosa · 2019 · Nutrients
5. The paradox of autophagy in Tuberous Sclerosis Complex
   Larissa Brussa Reis, Eduardo Cremonese Filippi‐Chiela, Patrícia Ashton‐Prolla, Fernanda Visioli, Clévia Rosset · 2021 · Genetics and Molecular Biology
6. Molecular profiling of sarcomas: new vistas for precision medicine
   Tariq Jassim Al-Zaid, Wei‐Lien Wang, Neeta Somaiah, Alexander J. Lazar · 2017 · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin
7. Translational regulation in the anoxic turtle, Trachemys scripta elegans
   Kama E. Szereszewski, Kenneth B. Storey · 2017 · Molecular and Cellular Biochemistry
8. Structure of the human TSC:WIPI3 lysosomal recruitment complex
   Charles Bayly-Jones, Christopher J. Lupton, Laura D’Andrea, Yong‐Gang Chang, Gareth D. Jones, Joel R. Steele, Hariprasad Venugopal, Ralf B. Schittenhelm, Michelle L. Halls, Andrew M. Ellisdon · 2024 · Science Advances
9. New roles for Notch in tuberous sclerosis
   Warren S. Pear · 2010 · Journal of Clinical Investigation
10. mTORC1 suppresses PIM3 expression via miR-33 encoded by the SREBP loci
    Ilana Kelsey, Marie Zbinden, Vanessa Byles, Margaret E. Torrence, Brendan D. Manning · 2017 · Scientific Reports
11. Oblongifolin C suppresses lysosomal function independently of TFEB nuclear translocation
    Man Wu, Yuanzhi Lao, Hongsheng Tan, Guang Xiu Lu, Yi Ren, Zhaoqing Zheng, Juan Yi, Wenwei Fu, Han‐Ming Shen, Hong‐Xi Xu · 2018 · Acta Pharmacologica Sinica
12. Emerging roles of autophagy in the development and treatment of urothelial carcinoma of the bladder
    Pratishtha Gupta, Niraj Kumar, Minal Garg · 2021 · Expert Opinion on Therapeutic Targets
13. Downregulation of LKB1/AMPK Signaling in Blood Mononuclear Cells Is Associated with the Severity of Guillain–Barre Syndrome
    Verica Paunović, Stojan Perić, Irena Vuković, Marina Stamenkovic, Emina Milošević, Danijela Stevanović, Miloš Mandić, Ivana Z. Basta, Ivana Berisavac, Mirjana Arsenijevic et al. · 2022 · Cells
14. Uterine histotroph and conceptus development: III. Adrenomedullin stimulates proliferation, migration and adhesion of porcine trophectoderm cells via AKT-TSC2-MTOR cell signaling pathway
    Bangmin Liu, Sudikshya Paudel, W. L. Flowers, Jorge A. Piedrahita, Xiaoqiu Wang · 2023 · Amino Acids
15. An Update on Autophagy as a Target in the Treatment of Alzheimer’s Disease
    Parnika M. Sose, Gaurav Doshi, Pravin Popatrao Kale · 2023 · Current Drug Targets
16. LPD-3 as a megaprotein brake for aging and insulin-mTOR signaling in C. elegans
    Taruna Pandey, Bingying Wang, Changnan Wang, Jenny Zu, Huichao Deng, Kang Shen, Goncalo Dias do Vale, Jeffrey G. McDonald, Dengke K. Ma · 2024 · Cell Reports
17. Clinicopathological and prognostic impact of somatic mutations in Chinese patients with clear cell renal cell carcinoma
    Hai Bi, Jipeng Yin, Lang Zhou, Yaqian Wu, Liyuan Ge, Min Lu, Lei Liu, Hongxian Zhang, Yongzhe Zhao, Cheng Liu et al. · 2020 · Translational Andrology and Urology
18. Pterocarpus marsupium extract extends replicative lifespan in budding yeast
    Mitchell B. Lee, Michael G. Kiflezghi, Mitsuhiro Tsuchiya, Brian M. Wasko, Daniel T. Carr, Priya A. Uppal, Katherine A. Grayden, Yordanos C. Elala, Tu Anh Nguyen, Jesse Wang et al. · 2021 · GeroScience
19. Developing Novel Experimental Models of m-TORopathic Epilepsy and Related Neuropathologies: Translational Insights from Zebrafish
    Murilo S. de Abreu, Konstantin A. Demin, Maria M. Kotova, Foad Mirzaei, Sanobar Shariff, Burhan Kantawala, Ksenia V. Zakharchenko, Tatiana O. Kolesnikova, Karen Dilbaryan, Artem Grigoryan et al. · 2023 · International Journal of Molecular Sciences
20. Restoration of Normal Cerebral Oxygen Consumption with Rapamycin Treatment in a Rat Model of Autism–Tuberous Sclerosis
    OAK ZA CHI, Chang‐Chih Wu, Xia Liu, Kang H. Rah, Estela Jacinto, Harvey R. Weiss · 2015 · NeuroMolecular Medicine
21. A novel TSC2 mutation in a Chinese family with tuberous sclerosis complex
    Yu Zheng, Xin Zhang, Hong Guo, Yun Bai · 2014 · Journal of Genetics
22. Potential Roles of mTOR and Protein Degradation Pathways in the Phenotypic Expression of Feed Efficiency in Broilers
    Walter G. Bottje Byung-Whi Kong · 2014 · Biochemistry & Physiology Open Access
23. The TSC1-mTOR-PLK Axis Regulates the Homeostatic Switch from Schwann Cell Proliferation to Myelination in a Stage-specific Manner
    Min-Qing Jiang, Rohit Rao, Jin-Cheng Wang, Jia-Jia Wang, Ling-Li Xu, Lai-Man Wu, Jonah R. Chan, Hui-Min Wang, Q. R. Lu · 2018 · Glia
24. IKBKE inhibits TSC1 to activate the mTOR/S6K pathway for oncogenic transformation
    Serkan İsmail Göktuna · 2018 · TURKISH JOURNAL OF BIOLOGY
25. p53 positively regulates osteoprotegerin-mediated inhibition of osteoclastogenesis by downregulating TSC2-induced autophagy in vitro
    Xishuai Tong, Jianhong Gu, Miaomiao Chen, Tao Wang, Hui Zou, Ruilong Song, Hongyan Zhao, Jianchun Bian, Zongping Liu · 2020 · Differentiation
26. The Rbfox1/LASR complex controls alternative pre-mRNA splicing by recognition of multipart RNA regulatory modules
    Parham Peyda, Chia-Ho Lin, Kelechi Onwuzurike, Douglas L. Black · 2025 · Genes & Development
27. Risk of Fat Mass- and Obesity-Associated Gene-Dependent Obesogenic Programming by Formula Feeding Compared to Breastfeeding
    Bodo Clemens Melnik, Ralf Weiskirchen, Wolfgang Stremmel, Swen Malte John, Gerd Schmitz · 2024 · Nutrients
28. Brain insulin resistance in Down syndrome: Involvement of PI3K-Akt/mTOR axis in early-onset of Alzheimer's disease and its potential as a therapeutic target
    Mansour Azimzadeh, Pike-See Cheah, King‐Hwa Ling · 2024 · Biochemical and Biophysical Research Communications
29. The TOR signalling pathway in fungal phytopathogens: A target for plant disease control
    Yun Song, Yaru Wang, Hua-Fan Zhang, M. Saddique, Xiu-Mei Luo, Mao-Zhi Ren · 2024 · Molecular plant pathology
30. A New Link in the Chain from Amino Acids to mTORC1 Activation
    Christopher G. Proud · 2011 · Molecular Cell
31. Tsc1 Regulates the Proliferation Capacity of Bone-Marrow Derived Mesenchymal Stem Cells
    María V. Guijarro, Laura S. Danielson, Marta Cañamero, Akbar Nawab, Carolina E. Abrahan, Eva Hernando, Glyn D. Palmer · 2020 · Cells
32. Recent insights into the pathophysiology of mTOR pathway dysregulation
    Deborah A. Altomare, Sarah B. Gitto · 2015 · Research and Reports in Biology
33. Role of mTOR in the regulation of skeletal muscle metabolism
    Natalia D. Golberg, Anastasiya M. Druzhevskaya, Viktor A. Rogozkin, Ildus I. Ahmetov · 2014 · Human Physiology
34. Novel small molecule drugs inhibit tumor cell metabolism and show potent anti-tumorigenic potential
    Christina Trojel‐Hansen, Kamille Dumong Erichsen, Mette Knak Christensen, Peter Buhl Jensen, Maxwell Sehested, Søren Jensby Nielsen · 2010 · Cancer Chemotherapy and Pharmacology
35. Evolution of TOR and Translation Control
    Bruno D. Fonseca, Tyson Ernst Graber, Huy‐Dung Hoang, Asier González, Alexander A. Soukas, Greco Hernández, Tommy Alain, Stephanie Louise Swift, Ronit Weisman, Christian Meyer et al. · 2016 · Springer eBooks
36. Investigation of the novel mTOR inhibitor AZD2014 in neuronal ischemia
    Gina Hadley, Daniel J. Beard, Zoi Alexopoulou, Brad A. Sutherland, Alastair Mitchell Buchan · 2019 · Neuroscience Letters
37. Hamartin: An Endogenous Neuroprotective Molecule Induced by Hypoxic Preconditioning
    Sijie Li, Chang­hong Ren, Christopher Stone, Ankush Chandra, Jiali Xu, Ning Li, Cong Han, Yuchuan Ding, Xunming Ji, Guo Shao · 2020 · Frontiers in Genetics
38. Crosstalk between the mTOR and DNA Damage Response Pathways in Fission Yeast
    John Patrick Alao, Luc Legon, Charalampos Rallis · 2021 · Cells
39. TSC-insensitive Rheb mutations induce oncogenic transformation through a combination of constitutively active mTORC1 signalling and proteome remodelling
    Jianling Xie, Stuart P. De Poi, Sean J. Humphrey, Leanne K. Hein, John B. Bruning, Wenru Pan, Luke A. Selth, Timothy J. Sargeant, Christopher G. Proud · 2021 · Cellular and Molecular Life Sciences
40. Emerging Link between Tsc1 and FNIP Co-Chaperones of Hsp90 and Cancer
    Sarah J. Backe, Rebecca Sager, Katherine A. Meluni, Mark R. Woodford, Dimitra Bourboulia, Mehdi Mollapour · 2022 · Biomolecules
41. mTORC1 Activity in Psoriatic Lesions Is Mediated by Aberrant Regulation through the Tuberous Sclerosis Complex
    Antonio Ferreri, Victoria Lang, Roland Kaufmann, Claudia Buerger · 2022 · Cells
42. Tuberous sclerosis complex: genetic basis and management strategies
    Peter B. Crino, Tsai · 2012 · Advances in Genomics and Genetics
43. Using high-throughput sequencing transcriptome data for INDEL detection: challenges for cancer drug discovery
    Gabriel Wajnberg, Fábio Passetti · 2016 · Expert Opinion on Drug Discovery
44. Doxycycline reduces the migration of tuberous sclerosis complex‐2 null cells ‐ effects on RhoA‐ GTP ase and focal adhesion kinase
    Ho Yin Ng, Brian Gregory George Oliver, Janette Kay Burgess, Vera P. Krymskaya, Judith Lee Black, Lyn Margaret Moir · 2015 · Journal of Cellular and Molecular Medicine
45. TUBEROUS SCLEROSIS COMPLEX
    Laura S. Farach, Kit Sing Au, Hope Northrup · 2020 · Wiley eBooks
46. Do we have a cure for tuberous sclerosis complex?
    Crino, Peter B. · 2008 · Epilepsy Currents
47. Histopathological features of fibrous cephalic plaques in tuberous sclerosis complex
    Alison M. Treichel, Deeti J. Pithadia, Chyi‐Chia Richard Lee, Oyetewa Oyerinde, Joel Moss, Thomas N. Darling · 2021 · Histopathology
48. Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling
    Mostafizur Rahman, Tuan Minh Nguyen, Gi Jeong Lee, Boram Kim, Mi Kyung Park, Chang Hoon Lee · 2024 · International Journal of Molecular Sciences
49. Consensus artificial intelligence-driven prognostic signature for predicting the prognosis of hepatocellular carcinoma: a multi-center and large-scale study
    Wen Wen, Rui Wang · 2025 · npj Precision Oncology
50. Deacetylated αβ-tubulin acts as a positive regulator of Rheb GTPase through increasing its GTP-loading
    Mi Nam Lee, Ara Koh, Dohyun Park, Jin‐Hyeok Jang, Dongoh Kwak, Hyeona Jeon, Jaeyoon John Kim, Eun-Jeong Choi, Heeyoon Jeong, Pann‐Ghill Suh et al. · 2012 · Cellular Signalling
51. Adding Some “Splice” to Stress Eating: Autophagy, ESCRT and Alternative Splicing Orchestrate the Cellular Stress Response
    Elias B. Habib, Allyson Cook, Sabateeshan Mathavarajah, Graham Dellaire · 2021 · Genes
52. Mutational analyses of the TSC1 and TSC2 genes in cases of tuberous sclerosis complex in Chinese Han children
    G.-X. Wang, Dong Wang, Changying Yi, J.-S. Qu, Yin‐Lin Wang · 2013 · Genetics and Molecular Research
53. Maternal protein restriction impairs nutrition and ovarian histomorphometry without changing p38MAPK and PI3K-AKT-mTOR signaling in adult rat ovaries
    Lucas Silva Côrtes, Henrique Spaulonci Silveira, Luiz Antônio Lupi, Talita de Mello Santos, Marília Martins Cavariani, Raquel Fantin Domeniconi, Letícia Barbosa Gaiotte, Diego Augusto Lopes Oliveira, Luís Antônio Justulin, Luiz Gustavo de Almeida Chuffa · 2020 · Life Sciences
54. Pulmonary Langerhans Cell Histiocytosis and Lymphangioleiomyomatosis Have Circulating Cells With Loss of Heterozygosity of the TSC2 Gene
    Davide Elia, Olga Torre, Chiara Vasco, Jens Geginat, Sergio Abrignani, Elisabetta Bulgheroni, Elena Carelli, Roberto Cassandro, Gustavo Pacheco–Rodriguez, Wendy K. Steagall et al. · 2022 · CHEST Journal
55. Critical role of Wat1/Pop3 in regulating the TORC1 signalling pathway in fission yeast S. pombe
    Lalita Panigrahi, Simmi Anjum, Shakil Ahmed · 2022 · Fungal Genetics and Biology
56. Oscillatory ERK Signaling and Morphology Determine Heterogeneity of Breast Cancer Cell Chemotaxis via MEK-ERK and p38-MAPK Signaling Pathways
    Ho, Kenneth K. Y., Srivastava, Siddhartha, Kinnunen, Patrick C., Garikipati, Krishna, Luker, Gary D., Luker, Kathryn E. · 2023 · Bioengineering
57. Are invertebrates relevant models in ageing research? Focus on the effects of rapamycin on TOR
    Cihan Süleyman Erdogan, Benni Winding Hansen, Ole Vang · 2016 · Mechanisms of Ageing and Development
58. Proinflammatory Stem Cell Signaling in Cardiac Ischemia
    Jeremy L. Herrmann, Troy A. Markel, Aaron M. Abarbanell, Brent R. Weil, Meijing Wang, Yue Wang, Jian Tan, Daniel R. Meldrum · 2009 · Antioxidants and Redox Signaling
59. Peer health advisor program to reduce the health risks of university students.
    M I Carey · 1984 · Europe PMC (PubMed Central)
60. S6K2 in Focus: Signaling Pathways, Post-Translational Modifications, and Computational Analysis
    Mahmoud I. M. Khalil, Mohamed Helal, Ahmed Fikry El-Sayed, Rana El Hajj, Jasmine Holail, Marwa Houssein, Ahmed Waraky, Olivier E. Pardo · 2024 · International Journal of Molecular Sciences
61. Buparlisib and Paclitaxel in Patients with Head and Neck Squamous Cell Carcinoma: Immunogenomic Biomarkers of Efficacy from the BERIL-1 Study
    Antoine Desîlets, Justin Lucas, Lisa Francesca Licitra, Sunny Y. Lu, Archie N. Tse, Tom Tang, Kevin Dreyer, Nanhai He, L. Birgerson, Sandrine J. Faivre et al. · 2025 · Targeted Oncology
62. Everolimus and sirolimus in the treatment of cardiac rhabdomyomas in neonates
    Daniel Hurtado-Sierra, Judy Ximena Ramos Garzón, Sandra Lucrecia Romero Guevara, Angie Yarlady Serrano García, Lyda Zoraya Rojas · 2025 · Pediatric Research
63. Evolution of growth factor signaling to the TSC complex to regulate mTORC1
    Kun Wang, Sophie E. Lockwood, Brendan D. Manning · 2025 · Science Signaling
64. Genetic Determinants of the Effects of Training on Muscle and Adipose Tissue Homeostasis in Obesity Associated with Lymphedema
    Andrea Vettori, Stefano Paolacci, Paolo Enrico Maltese, Karen Louise Herbst, Marina Cestari, Sandro Michelini, Serena Michelini, Michele Samaja, Matteo Bertelli · 2020 · Lymphatic Research and Biology
65. Seizure reduction in TSC2 ‐mutant mouse model by an mTOR catalytic inhibitor
    Sameer C. Dhamne, Meera E. Modi, Audrey J. Gray, Simone Bonazzi, Lucas Craig, Elizabeth Bainbridge, Lahin K. Lalani, Chloe E. Super, Samantha M Schaeffer, Ketthsy Capre et al. · 2023 · Annals of Clinical and Translational Neurology
66. Tumor antigen presentation and the associated signal transduction during carcinogenesis
    Sohom Naskar, Nawaneetan Sriraman, Ankita Sarkar, Nitika Mahajan, Koustav Sarkar · 2024 · Pathology - Research and Practice
67. Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components
    Anurag Saxena, Julian R. Sampson · 2014 · Seminars in Cell and Developmental Biology
68. The TSC1–TSC2 Complex
    2010 · The Enzymes
69. Small-molecule signal-transduction inhibitors: targeted therapeutic agents for single-gene disorders: Figure 1
    David Mark Davies, Julian R. Sampson · 2009 · Journal of Medical Genetics
70. Antibody αPEP13h Reacts With Lymphangioleiomyomatosis Cells in Lung Nodules
    Julio C. Valencia, Wendy K. Steagall, Yi Zhang, Patricia A. Fetsch, Andrea D. Abati, Katsuya Tsukada, Eric M. Billings, Vincent J. Hearing, Zu‐Xi Yu, Gustavo Pacheco–Rodriguez et al. · 2014 · CHEST Journal
71. Activation of AMPK Stimulates Neurotensin Secretion in Neuroendocrine Cells
    Jing Li, Jun Song, Heidi L. Weiss, Todd Weiss, Courtney M. Townsend, Bernard Mark Evers · 2015 · Molecular Endocrinology
72. A novel fusion of PDGFRB to TSC1, an intrinsic suppressor of mTOR-signaling pathway, in a chronic eosinophilic leukemia patient with t(5;9)(q32;q34)
    Yue Zhang, Shiqiang Qu, Qianfei Wang, Jianyong Li, Zefeng Xu, Tiejun Qin, Gang Huang, Zhijian Xiao · 2018 · Leukemia & lymphoma/Leukemia and lymphoma
73. Lymphangioleiomyomatosis: New Treatment Perspectives
    Elżbieta Radzikowska · 2015 · Lung
74. Targeting phosphoinositide‐3‐kinase pathway in biliary tract cancers: A remedial route?
    Kaavya Jayaramayya, Mahalaxmi Iyer, Subramaniam Mohana Devi, Kumaran Sivanandan Santhy, Balachandar Vellingiri · 2018 · Journal of Cellular Physiology
75. HK2 Mediated Glycolytic Metabolism in Mouse Photoreceptors Is Not Required to Cause Late Stage Age-Related Macular Degeneration-Like Pathologies
    Shun-Yun Cheng, Anneliese Malachi, Joris Cipi, Shan Ma, Richard S. Brush, Martin‐Paul Agbaga, Claudio Punzo · 2021 · Biomolecules
76. mTOR pathway gene expression in association with race and clinicopathological characteristics in Black and White breast cancer patients
    Mmadili N. Ilozumba, Song Yao, Adana A. M. Llanos, Angela R. Omilian, Weizhou Zhang, Susmita Datta, Chi‐Chen Hong, Warren Davis, Thaer Khoury, Elisa Victoria Bandera et al. · 2022 · Discover Oncology
77. Genetics and Epigenetics of Pancreatic Neuroendocrine Tumors and Pulmonary Carcinoids
    Koen M.A. Dreijerink, Jules L. Derks, Ivana Cataldo, Aldo Scarpa, Gerlof Dirk Valk, Ernst‐Jan M. Speel · 2015 · Frontiers of hormone research
78. Wnt-induced proteolytic targeting: Figure 1.
    Katherine A. Jones, Caroline R. Kemp · 2008 · Genes & Development
79. Insulinoma and Tuberous Sclerosis: A Possible Mechanistic Target of Rapamycin (mTOR) Pathway Abnormality?
    Kang, Michael Yoon, Yeoh, Joey, Pondicherry, Ashwini, Rahman, Habib, Dissanayake, Ajith · 2017 · Journal of the Endocrine Society
80. Development and application of a targeted phosphoproteomics method for analysing the mTOR pathway dynamics in zebrafish PAC2 cell line
    Nikolai Huwa, René Schönenberger, Ksenia J. Groh · 2025 · Journal of Proteomics
81. Moving Towards Dawn: KRas Signaling and Treatment in Pancreatic Ductal Adenocarcinoma
    Sankha Bhattacharya, Tarun Rajpurohit · 2022 · Current Molecular Pharmacology
82. An Integral Approach to the Molecular Diagnosis of Tuberous Sclerosis Complex
    Laura Campello Blasco, Leticia Iranzo-Nuez, Ricard López Ortega, Desirée Martínez-Cruz, María Camprodón-Gómez, Anna Tenés, Maria Antolı́n, Eduardo Fidel Tizzano, Elena García‐Arumí · 2023 · Journal of Molecular Diagnostics
83. Targeting autophagy with small-molecule activators for potential therapeutic purposes
    Zhichao Fan, Lin‐Xi Wan, Jiang Wei, Bo Liu, Dongbo Wu · 2023 · European Journal of Medicinal Chemistry
84. Comprehensive Transcriptome Analysis Reveals the Distinct Gene Expression Patterns of Tumor Microenvironment in HPV-Associated and HPV-Non Associated Tonsillar Squamous Cell Carcinoma
    Reham M. Alahmadi, Najat Marraiki, Mohammed Alswayyed, Hatim A. Khoja, Abdullah E. Al-Anazi, Rawan Mosleh Alahmadi, Meshael M. Alkusayer, Bandar Alosaimi, Maaweya Awadalla · 2023 · Cancers
85. A comprehensive model for the biochemistry of ageing, senescence and longevity
    Hiskias G. Keizer, Ruud Brands, Ronald S. Oosting, Willem Seinen · 2024 · Biogerontology
86. Inhibition of the rapamycin-insensitive mTORC1 /4E-BP1 axis attenuates TGF-β1-induced fibrotic response in human Tenon's fibroblasts
    Jiayu Zou, Bozhao Wu, Tao Yan, Zuimeng Liu, Huanyu Zhao, Pin Wang, Yuanbo Liang, Jia Qu, Shaodan Zhang · 2024 · Experimental Eye Research
87. Anticancer Effect of PtIIPHENSS, PtII5MESS, PtII56MESS and Their Platinum(IV)-Dihydroxy Derivatives against Triple-Negative Breast Cancer and Cisplatin-Resistant Colorectal Cancer
    Maria George Elias, Shadma Fatima, Timothy J. Mann, Shawan Karan, Meena Mikhael, Paul DE SOUZA, Christopher P. Gordon, Kieran F. Scott, Janice Rae Aldrich-Wright · 2024 · Cancers
88. The dual role of the TSC complex in cancer
    Josephine Hartung, Christine Müller, Cornelis F. Calkhoven · 2024 · Trends in Molecular Medicine
89. Histopathological evidence of cellular alterations in the dentate gyrus is associated with aberrant RB1CC1-ATG16L1 expression in the hippocampus among older adults with chronic schizophrenia: A pilot post-mortem study
    Andreas S. Lappas, Μαρία Ιωάννου, George N. Christodoulou · 2024 · Schizophrenia Research
90. Distinct UPR and Autophagic Functions Define Cell-Specific Responses to Proteotoxic Stress in Microglial and Neuronal Cell Lines
    Helena Dominguez‐Martín, Elena Gavilán, Celia Parrado, Miguel Ángel Burguillos, Paula Daza, Diego Ruano · 2024 · Cells
91. mTORC1 in the Control of Myogenesis and Adult Skeletal Muscle Mass
    Marita A. Wallace, David C. Hughes, Keith Baar · 2016 · Elsevier eBooks
92. Possible Biomarkers and Contributing Factors of Psychosis: a Review
    Monu Yadav, Naresh Kumar, Anil Kumar, Deepak Kumar Jindal, Mini Dahiya · 2021 · Current Pharmacology Reports
93. The endocrine and epigenetic impact of persistent cow milk consumption on prostate carcinogenesis
    Bodo Clemens Melnik, Swen Malte John, Ralf Weiskirchen, Gerd Schmitz · 2022 · Journal of Translational Genetics and Genomics
94. MicroRNA Expression Profile in TSC Cell Lines and the Impact of mTOR Inhibitor
    Bartłomiej Pawlik, Szymon Grabia, Urszula Smyczyńska, Wojciech M Fendler, Izabela Dróźdż, Ewa Liszewska, Jacek Jaworski, Katarzyna Kotulska, Sergiusz Jóźwiak, Wojciech Michal Mlynarski et al. · 2022 · International Journal of Molecular Sciences
95. Tuberous Sclerosis Complex Kidney Lesion Pathogenesis: A Developmental Perspective
    Adam Pietrobon, William L. Stanford · 2023 · Journal of the American Society of Nephrology
96. mTOR signaling in mice with dysfunctional cardiac ryanodine receptor ion channel
    Gerhard Meissner, Tai-Qin Huang, Min-Xu Zou, Daniel A. Pasek · 2015 · Journal of Receptor Ligand and Channel Research
97. Crossing Paths in Human Renal Cell Carcinoma (hRCC)
    Guadalupe Aparicio Gallego, Vanessa Medina Villaamil, Enrique Grande, I. Santamarina Caínzos, Luís Antón Aparicio · 2012 · International Journal of Molecular Sciences
98. mTOR kinase inhibitor potentiates apoptosis of PI3K and MEK inhibitors in diagnostically defined subpopulations
    Ulka Vijapurkar, Liliane Robillard, Siqun Zhou, Michael Y. Degtyarev, Kui Lin, Tom Truong, Jarrod R. Tremayne, Leanne Berry Ross, Zhonghua Pei, Lori S. Friedman et al. · 2012 · Cancer Letters
99. Hyperactivated mTORC1 downregulation of FOXO3a/PDGFRα/AKT cascade restrains tuberous sclerosis complex-associated tumor development
    Li Wang, Zhaofei Ni, Yujie Liu, Shuang Ji, Fuquan Jin, Keguo Jiang, Junfang Ma, Cuiping Ren, Hongbing Zhang, Zhongdong Hu et al. · 2017 · Oncotarget
100. Molecular genetic diagnostics of tuberous sclerosis complex in Bulgaria: six novel mutations in the TSC1 and TSC2 genes
     Maria Glushkova, Veneta Bojinova, Maya Koleva, Petya S. Dimova, Maria Bojidarova, Ivan Litvinenko, Т. Тодоров, E. Iluca, C. Calusaru, E. Neagu et al. · 2018 · Journal of Genetics